| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 348 | 1.579 | 20.551 | 27.005 | 41.179 | 60.009 | 72.881 | 72.256 |
| Total Income - EUR | - | 0 | 348 | 1.579 | 20.551 | 27.026 | 41.179 | 60.009 | 72.881 | 72.256 |
| Total Expenses - EUR | - | 5.711 | 11.672 | 9.960 | 18.439 | 19.161 | 23.762 | 36.022 | 29.637 | 39.684 |
| Gross Profit/Loss - EUR | - | -5.711 | -11.324 | -8.381 | 2.112 | 7.865 | 17.417 | 23.987 | 43.244 | 32.572 |
| Net Profit/Loss - EUR | - | -5.711 | -11.334 | -8.399 | 1.467 | 7.054 | 16.206 | 23.477 | 42.625 | 30.719 |
| Employees | - | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
Check the financial reports for the company - Derma Four S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 3.944 | 6.336 | 4.683 | 3.085 | 1.539 | 452 | 0 | 0 | 77.015 |
| Current Assets | - | 66 | 111 | 1.102 | 2.741 | 4.264 | 12.539 | 57.935 | 121.540 | 37.578 |
| Inventories | - | 0 | 0 | 0 | 0 | 68 | 0 | 0 | 0 | 174 |
| Receivables | - | 0 | 0 | 183 | 722 | 2.965 | 3.535 | 49.562 | 102.876 | 25.671 |
| Cash | - | 66 | 111 | 919 | 2.019 | 1.230 | 9.003 | 8.373 | 18.664 | 11.733 |
| Shareholders Funds | - | -5.489 | -16.730 | -24.822 | -22.875 | -15.387 | 1.160 | 24.649 | 67.199 | 94.029 |
| Social Capital | - | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 9.499 | 23.177 | 30.607 | 28.701 | 21.190 | 11.830 | 33.286 | 54.341 | 20.564 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derma Four S.r.l.